[Is GHB use in Switzerland on the rise?]

Praxis (Bern 1994). 2004 Jul 28;93(31-32):1247-9. doi: 10.1024/0369-8394.93.31.1247.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • 4-Butyrolactone / administration & dosage
  • 4-Butyrolactone / pharmacology
  • Adjuvants, Anesthesia / administration & dosage
  • Adjuvants, Anesthesia / pharmacology
  • Adjuvants, Anesthesia / therapeutic use
  • Administration, Oral
  • Anesthetics, Intravenous / administration & dosage
  • Anesthetics, Intravenous / pharmacology
  • Anesthetics, Intravenous / therapeutic use
  • Brain / drug effects
  • Humans
  • Illicit Drugs*
  • Sodium Oxybate* / administration & dosage
  • Sodium Oxybate* / adverse effects
  • Sodium Oxybate* / pharmacology
  • Sodium Oxybate* / poisoning
  • Sodium Oxybate* / therapeutic use
  • Solvents / administration & dosage
  • Substance-Related Disorders*
  • Switzerland
  • Time Factors

Substances

  • Adjuvants, Anesthesia
  • Anesthetics, Intravenous
  • Illicit Drugs
  • Solvents
  • Sodium Oxybate
  • 4-Butyrolactone